| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |